Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

Columnist Ben Hofmeister explains how songs such as "No One Is to Blame" have become part of the soundtrack of his life with MS.

Tired of MS fatigue controlling your life? In the premiere episode of “Get Tough on Multiple Sclerosis,” Dr. Susan Payrovi ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...

The study estimated annual mortality rates for 5,797 individuals with MS compared with 28,807 controls with a similar age, ...

Stress management strategies such as mindfulness and exercise can help you manage your multiple sclerosis (MS) diagnosis.

TG Therapeutics will use MaxCyte’s technology to advance toward a clinical trial its azer-cel CAR T-cell therapy for ...

When managing a complex chronic condition like multiple sclerosis, having good communication and trust with your doctor is ...

Multiple sclerosis home adaptations that include adaptive equipment and technology can help prevent falls for people living ...

Scientists interviewed 17 patients who reported feeling unmoored by a disease that has stripped away their sense of control ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...